These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 7285624)
41. [Methotrexate-induced liver cirrhosis in psoriasis. Determination of tissue type and histopathological assessment]. Zachariae H; Kissmeyer-Nielsen F; Kragballe K; Thestrup-Pedersen K; Søgaard H Ugeskr Laeger; 1980 Aug; 142(34):2182-4. PubMed ID: 7423637 [No Abstract] [Full Text] [Related]
42. [Methotrexate therapy in psoriasis]. Bournerias I Rev Prat; 2004 Jan; 54(1):52-5. PubMed ID: 15049601 [TBL] [Abstract][Full Text] [Related]
43. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics. Zachariae H; Søgaard H; Heickendorff L Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230 [TBL] [Abstract][Full Text] [Related]
44. Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study. Ranjan N; Sharma NL; Shanker V; Mahajan VK; Tegta GR J Dermatolog Treat; 2007; 18(5):295-300. PubMed ID: 17852635 [TBL] [Abstract][Full Text] [Related]
45. Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens. Dahl MG; Gregory MM; Scheuer PJ Br Med J; 1972 Mar; 1(5801):654-6. PubMed ID: 5015292 [TBL] [Abstract][Full Text] [Related]
46. Drug reactions XV. Methotrexate, psoriasis and the liver. Almeyda J; Barnardo D; Baker H Br J Dermatol; 1971 Sep; 85(3):302-5. PubMed ID: 4939241 [No Abstract] [Full Text] [Related]
47. Dynamic hepatic scintigraphy in the screening of psoriatic patients for methotrexate-induced hepatotoxicity. McHenry PM; Bingham EA; Callender ME; Delvin PB; O'Hara MD; Ferguson WR; Laird JD; Burrows D Br J Dermatol; 1992 Aug; 127(2):122-5. PubMed ID: 1390139 [TBL] [Abstract][Full Text] [Related]
48. Magnetic resonance imaging as a screening procedure for methotrexate induced liver damage. Rademaker M; Webb JA; Lowe DG; Meyrick-Thomas RH; Kirby JD; Munro DD Br J Dermatol; 1987 Sep; 117(3):311-6. PubMed ID: 3676081 [TBL] [Abstract][Full Text] [Related]
52. Methotrexate Dosing Regimen for Plaque-type Psoriasis: A Systematic Review of the Use of Test-dose, Start-dose, Dosing Scheme, Dose Adjustments, Maximum Dose and Folic Acid Supplementation. Menting SP; Dekker PM; Limpens J; Hooft L; Spuls PI Acta Derm Venereol; 2016 Jan; 96(1):23-8. PubMed ID: 25721372 [TBL] [Abstract][Full Text] [Related]
53. Methotrexate in psoriasis. A brief review of indications, usage, and complications of methotrexate therapy. Hanno R; Gruber GG; Owen LG; Callen JP J Am Acad Dermatol; 1980 Feb; 2(2):171-4. PubMed ID: 7364974 [TBL] [Abstract][Full Text] [Related]
54. [Apropos of 2 accidents during general treatments with methotrexate]. Amblard P; Dugois P; Imbert R; Fillon JP; Martel J Bull Soc Fr Dermatol Syphiligr; 1971; 78(1):85-7. PubMed ID: 5565944 [No Abstract] [Full Text] [Related]
55. Complete recovery of complicated methotrexate-induced liver cirrhosis in a patient with psoriasis: A case report. El Hage S; Akiki D; El Masri J; Roustom M Transpl Immunol; 2022 Feb; 70():101492. PubMed ID: 34767946 [TBL] [Abstract][Full Text] [Related]